Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AML
ClinicalTrials.gov study NCT02891278. IPD Sharing: NO. Countries: 1. Publications: 0.
Venetoclax in Combination with 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy
ClinicalTrials.gov study NCT05833438. IPD Sharing: YES. Countries: 1. Publications: 0.
Gamma Delta T Cells in AML
ClinicalTrials.gov study NCT03885076. IPD Sharing: NO. Countries: 1. Publications: 0.
VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05603884. IPD Sharing: NO. Countries: 1. Publications: 0.
MRD Response-adapted Allo-HSCT for Adverse-risk AML
ClinicalTrials.gov study NCT06301425. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPY
ClinicalTrials.gov study NCT02992860. IPD Sharing: NO. Countries: 2. Publications: 0.
VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS
ClinicalTrials.gov study NCT06536959. IPD Sharing: NO. Countries: 1. Publications: 0.
NGS in AML Relapse
ClinicalTrials.gov study NCT03582241. IPD Sharing: Not stated. Countries: 1. Publications: 0.
2321GCCC: CRD3874-SI in Patients With Relapsed/Refractory AML
ClinicalTrials.gov study NCT06626633. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT05829226. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDS
ClinicalTrials.gov study NCT04668885. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML
ClinicalTrials.gov study NCT02091245. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of FLAG Regimen for the Treatment of Patients With AML
ClinicalTrials.gov study NCT03600558. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS
ClinicalTrials.gov study NCT03066648. IPD Sharing: NO. Countries: 8. Publications: 0.
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
ClinicalTrials.gov study NCT06788756. IPD Sharing: UNDECIDED. Countries: 8. Publications: 0.
Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
ClinicalTrials.gov study NCT04628026. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Safety and Efficacy of Allogenic NK Cells in Combination With Chemotherapy in the Treatment of r/r AML After Allo-HSCT
ClinicalTrials.gov study NCT05744440. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Optimizing Induction Chemotherapy Regimens for ND Elderly AML Patients Who Are Eligible for Intense Chemotherapy
ClinicalTrials.gov study NCT06066242. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00875745. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NLA101 in Adults Receiving High Dose Chemotherapy for AML
ClinicalTrials.gov study NCT03301597. IPD Sharing: Not stated. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.